Genetic assays have transformed how clinicians approach treatment decisions in breast cancer, offering both predictive and ...
Background Although the increased risk of cardiovascular disease in patients with SLE is well-documented, effective tools for risk stratification remain elusive. This study sought to explore the ...
A Decision Score provides prognostic discrimination for 10-year locoregional recurrence, with rising score associated with ...
Objective To estimate the prevalence of potential overtreatment of type 2 diabetes mellitus (T2DM) among older adults and to develop and compare predictive models to identify patient and physician ...
Abbott’s major takeover of Exact Sciences showcases a rising push to leverage cancer tests in precision oncology therapy and ...
Like many first-time mothers, Lisette Lopez-Rose thought childbirth would usher in a time of joy. Instead, she had panic attacks as she imagined that something bad was going to happen to her baby, and ...
Please provide your email address to receive an email when new articles are posted on . Low placental growth factor had a significant association with early-onset preeclampsia for women with sickle ...
The nature of product recall management has fundamentally changed. Once viewed primarily as a regulatory compliance chore managed by quality and legal teams, today’s automotive recall is an immediate ...
Oncology-focused biotech company SkylineDx said results from its MERLIN_001 trial, the largest evaluation of a genomic test in cutaneous melanoma, were published in the October 2025 issue of JAMA ...
Grail is on a mission to have its cancer blood test become a core part of U.S. screening for a range of tumors. Now, it’s detailing its latest data as it heads to the FDA. Back in June, Grail revealed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results